Can secondary hypogammaglobulinemia result from medications, hematologic disorders, kidney protein loss, or gastrointestinal protein loss?

Secondary hypogammaglobulinemia is well established as an acquired finding with several distinct mechanisms. In an 83-year-old, interpretation should integrate longitudinal immunoglobulin results, medication exposure, protein-loss features, infection history, and assessment for hematologic disease rather than relying on a single low value or class pattern.

Established causes and clinical evaluation

• Medications: Immunosuppressive and cancer therapies—especially B-cell-depleting agents such as rituximab—can reduce immunoglobulins. Rituximab depletes CD20-positive naïve, mature, and memory B cells; depletion commonly persists 6–12 months. Risk is greater with low baseline IgG, cumulative cyclophosphamide exposure, and concurrent immunosuppression.
• Hematologic/marrow disorders: CLL, multiple myeloma, and lymphoma can impair normal antibody production. In myeloma, a monoclonal protein may coexist with suppression of uninvolved immunoglobulins. CBC, serum protein electrophoresis/immunofixation, free light chains, immune phenotyping, and selected vaccine-antibody testing can help distinguish causes.
• Renal and gastrointestinal loss: Nephrotic proteinuria causes urinary loss of immunoglobulins, most often reducing IgG and IgA alongside albumin. Protein-losing enteropathy causes nonselective plasma-protein loss and may reduce IgG, IgA, and IgM; fecal alpha-1-antitrypsin clearance can support this diagnosis.

Immunoglobulin-pattern interpretation

• Broad reduction across classes is more consistent with generalized protein loss, particularly enteric loss. In a 54-patient nephrotic-syndrome cohort, IgG and IgA were low across histologic diagnoses, while about half with minimal-change disease had elevated IgM.
• Thus, isolated low IgM is not a typical renal protein-loss pattern and should not automatically be attributed to generalized loss.

Bottom line

• Medication exposure, hematologic disease, kidney protein loss, and gastrointestinal protein loss are established secondary causes; generalized loss is better supported as causing multi-class reduction than isolated IgM deficiency.